BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27111595)

  • 1. [Case Report on Treatment of Metastatic Breast Cancer with Trastuzumab during Pregnancy].
    Rasenack R; Gaupp N; Rautenberg B; Stickeler E; Prömpeler H
    Z Geburtshilfe Neonatol; 2016 Apr; 220(2):81-3. PubMed ID: 27111595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab use for metastatic breast cancer in pregnancy.
    Sekar R; Stone PR
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trastuzumab administration during pregnancy: an update.
    Andrikopoulou A; Apostolidou K; Chatzinikolaou S; Bletsa G; Zografos E; Dimopoulos MA; Zagouri F
    BMC Cancer; 2021 Apr; 21(1):463. PubMed ID: 33902516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pertuzumab and trastuzumab during pregnancy.
    Yildirim N; Bahceci A
    Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
    Beale JM; Tuohy J; McDowell SJ
    Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
    Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
    Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
    [No Abstract]   [Full Text] [Related]  

  • 7. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
    Watson WJ
    Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab treatment for breast cancer during pregnancy.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Can Fam Physician; 2008 Jan; 54(1):31-2. PubMed ID: 18208949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pregnancy associated breast cancer].
    Székely B; Langmár Z; Somlai K; Szentmártoni G; Szalay K; Korompay A; Szász AM; Kulka J; Bánhidy F; Dank M
    Orv Hetil; 2010 Aug; 151(32):1299-303. PubMed ID: 20656670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab in pregnancy associated with poor fetal outcome.
    Witzel ID; Müller V; Harps E; Janicke F; Dewit M
    Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
    [No Abstract]   [Full Text] [Related]  

  • 11. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
    Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
    Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
    Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of massive liver metastasis of breast cancer during pregnancy: first report of a complete remission with trastuzumab and review of literature.
    Aktoz F; Yalcin AC; Yüzdemir HS; Akata D; Gültekin M
    J Matern Fetal Neonatal Med; 2020 Apr; 33(7):1266-1271. PubMed ID: 30153764
    [No Abstract]   [Full Text] [Related]  

  • 14. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up.
    Andrade JM; Brito LG; Moises EC; Amorim AC; Rapatoni L; Carrara HH; Tiezzi DG
    Anticancer Drugs; 2016 Apr; 27(4):369-72. PubMed ID: 26825868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
    Azim HA; Metzger-Filho O; de Azambuja E; Loibl S; Focant F; Gresko E; Arfi M; Piccart-Gebhart M
    Breast Cancer Res Treat; 2012 May; 133(1):387-91. PubMed ID: 22367645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of breast cancer during pregnancy: an observational study.
    Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
    Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios.
    Warraich Q; Smith N
    J Obstet Gynaecol; 2009 Feb; 29(2):147-8. PubMed ID: 19274553
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.
    Xia LY; Hu QL; Zhou Q
    BMC Womens Health; 2021 Apr; 21(1):169. PubMed ID: 33882925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes.
    Córdoba O; Llurba E; Saura C; Rubio I; Ferrer Q; Cortés J; Xercavins J
    Breast; 2013 Aug; 22(4):515-9. PubMed ID: 23116970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA.
    Spano JP; Beuzeboc P; Coeffic D; Arnould L; Lortholary A; Andre F; Ferrero JM
    Breast; 2015 Aug; 24(4):376-83. PubMed ID: 25913287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.